Liu Rui, Xu Li-Xia, Tong Lin-Jian, Wu Hai-Yang, Guo Qiang, Sun Zhi-Ming, Yan Hua
Clinical College of Neurology, Neurosurgery and Neurorehabilitation, Tianjin Medical University, Tianjin, 300070, China.
Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institute, Tianjin Huanhu Hospital, Tianjin, 300350, China.
Eur J Pharmacol. 2024 Jul 5;974:176604. doi: 10.1016/j.ejphar.2024.176604. Epub 2024 Apr 20.
Osteoporosis (OP) is a metabolic bone disease with a high incidence rate worldwide. Its main features are decreased bone mass, increased bone fragility and deterioration of bone microstructure. It is caused by an imbalance between bone formation and bone resorption. Ginsenoside is a safe and effective traditional Chinese medicine (TCM) usually extracted from ginseng plants, having various therapeutic effects, of which the effect against osteoporosis has been extensively studied. We searched a total of 44 relevant articles with using keywords including osteoporosis, ginsenosides, bone mesenchymal cells, osteoblasts, osteoclasts and bone remodeling, all of which investigated the cellular mechanisms of different types of ginsenosides affecting the activity of bone remodeling by mesenchymal stem cells, osteoblasts and osteoclasts to counteract osteoporosis. This review describes the different types of ginsenosides used to treat osteoporosis from different perspectives, providing a solid theoretical basis for future clinical applications.
骨质疏松症(OP)是一种在全球发病率较高的代谢性骨病。其主要特征是骨量减少、骨脆性增加和骨微结构破坏。它是由骨形成与骨吸收之间的失衡引起的。人参皂苷是一种通常从人参植物中提取的安全有效的中药,具有多种治疗作用,其中抗骨质疏松的作用已得到广泛研究。我们使用包括骨质疏松症、人参皂苷、骨间充质细胞、成骨细胞、破骨细胞和骨重塑等关键词共检索到44篇相关文章,所有这些文章都研究了不同类型人参皂苷通过间充质干细胞、成骨细胞和破骨细胞影响骨重塑活性以对抗骨质疏松症的细胞机制。本综述从不同角度描述了用于治疗骨质疏松症的不同类型人参皂苷,为未来的临床应用提供了坚实的理论基础。